RxSight (RXST) Q2 2026 Earnings Call Transcript

RxSight held its second quarter 2026 earnings conference call on August 5, featuring newly appointed President and Chief Executive Officer Aziz Mottiwala alongside Chief Financial Officer Mark Wilterding. The company reported total revenue of $33.7 million for the three months ended June 30, 2026, which included $6.5 million related to a strategic collaboration with Alcon.
Excluding Alcon-related revenue, core product sales totaled $27.2 million, representing a 19% decline from the prior year p